INFED Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Infed, and what generic alternatives are available?
Infed is a drug marketed by Allergan and is included in one NDA.
The generic ingredient in INFED is ferric oxyhydroxide. There are twenty drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the ferric oxyhydroxide profile page.
Summary for INFED
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 33 |
Drug Prices: | Drug price information for INFED |
What excipients (inactive ingredients) are in INFED? | INFED excipients list |
DailyMed Link: | INFED at DailyMed |
Pharmacology for INFED
Drug Class | Parenteral Iron Replacement Phosphate Binder |
Mechanism of Action | Phosphate Chelating Activity |
US Patents and Regulatory Information for INFED
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Allergan | INFED | ferric oxyhydroxide | INJECTABLE;INJECTION | 017441-001 | Approved Prior to Jan 1, 1982 | BP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |